OurCrowd

Last updated: Jul 31, 2026

Jerusalem-headquartered private-market investment platform that gives accredited investors and institutions access to curated startups, venture funds, and other alternative assets. OurCrowd combines sourcing, diligence, syndication, fund administration, and portfolio support; it is a financial-market intermediary rather than a proprietary defense-technology developer.

Visit Website

Company Overview

OurCrowd operates a global venture and alternatives investment platform founded in Jerusalem in 2013. Its public offering spans individually selected startups, managed and rule-based venture funds, late-stage private companies, and other private-market alternatives. The platform is oriented toward accredited investors and institutional participants, while portfolio companies can receive introductions, recruiting assistance, industry mentors, and connections to multinational partners. OurCrowd therefore combines elements of a venture investor, syndication platform, fund manager, and investor-relations operation rather than selling a single software product.

The core operating capability is a repeatable private-market workflow: source companies through an international network, screen and diligence them, secure allocations alongside institutional or venture co-investors, structure the opportunity for eligible participants, and provide ongoing reporting after the transaction. OurCrowd says its investment team reviews roughly 150–200 companies per month and selects only a small subset for opportunities on the platform. It also states that it invests its own capital alongside its investor community. These claims are company-reported, but they describe a meaningful process advantage if the organization can maintain diligence quality and access through changing venture cycles.

The customer problem is access and intermediation. Family offices, high-net-worth individuals, corporations, and institutions may want exposure to private technology markets without recreating a global sourcing network, investment committee, legal workflow, and portfolio-monitoring function. OurCrowd lowers that operational barrier, but it does not remove the fundamental risks of private investing: securities are illiquid, valuations are difficult to compare, outcomes are highly dispersed, and eligibility and disclosure rules vary by jurisdiction. An October 2025 company one-pager reports $2.6 billion in committed funds, 500 portfolio companies, 68 funds, 73 exits, and seven incubators; these are useful scale signals but remain company-reported and should be reconciled against audited, regulatory, and fund-level materials before being used for hard underwriting. The figures also describe different measures of activity, so they should not be treated as equivalent to realized investor returns.

Competition is broad rather than limited to one direct peer. AngelList, Republic, Wefunder, and SeedInvest compete for online access and syndication; EquityZen and Forge address secondary private-market transactions; traditional venture firms, private banks, fund-of-funds managers, and direct institutional relationships are important substitutes. OurCrowd’s differentiation is its Israeli innovation network, recognizable global brand, curated deal presentation, ability to offer both direct opportunities and funds, and claimed practice of investing alongside members. The defensibility of that position depends on continued proprietary or preferential access, disciplined selection, investor trust, regulatory execution, and portfolio outcomes. A polished interface alone is unlikely to be a durable moat in a crowded private-market infrastructure category.

For national-security and dual-use analysis, the relevant asset is the network rather than the platform technology. The October 2025 one-pager describes exposure across AI, enterprise software, cybersecurity, mobility, energy, and other categories; some portfolio companies may have security applications, but portfolio composition is not proof of defense revenue or government adoption. OurCrowd’s public communications also highlight portfolio activity in space and security-adjacent areas, which creates ecosystem and dealflow relevance for strategic readers. It does not establish that OurCrowd itself develops, deploys, certifies, or operates military systems, nor that every security-adjacent portfolio company has defense traction. The company should consequently be treated as an access and intelligence node with indirect dual-use relevance, not as a defense startup or a substitute for technical, export-control, customer, and program-level diligence on individual portfolio companies.

Strategic Fit Assessment

OurCrowd is relevant to a strategic map of Israeli technology finance, but it is not a priority direct target for a dual-use and deep-tech database. The organization is a mature private financial intermediary whose value rests on sourcing, underwriting, distribution, investor trust, and portfolio support rather than proprietary frontier technology. A diligence case would require evidence on recurring platform economics, realized performance, regulatory posture, conflicts management, and the quality of access to security-relevant deals; public marketing claims alone are insufficient.

Strategic Value to U.S.-Israel Alliance

OurCrowd has strategic value as a market-access and ecosystem-intelligence node. It can aggregate visibility into Israeli and international startups, funds, and alternative assets, and its network may help surface companies relevant to cybersecurity, autonomy, AI, sensing, space, or resilience. That value is indirect: OurCrowd does not itself supply military capability, guarantee portfolio-company performance, or replace technical diligence, export-control review, customer validation, or government-program evidence.

Key Technologies

  • Private-market investment and portfolio-management platform
  • Accredited-investor onboarding, eligibility, and compliance workflows
  • Venture deal sourcing, screening, and investment-committee diligence
  • Syndication, co-investment, and special-purpose investment structuring
  • Managed, rule-based, and thematic venture-fund administration
  • Investor reporting, portfolio updates, and private-asset documentation
  • Cross-border capital allocation and private-market transaction operations

Use Cases & Applications

  • Accredited-investor access to curated early-stage and late-stage private companies
  • Institutional and family-office co-investment alongside venture funds
  • Thematic diversification through managed and rule-based venture funds
  • Israeli innovation sourcing for global investors without a local venture team
  • Portfolio monitoring, investor communications, and post-investment support
  • Corporate access to startup dealflow, technology scouting, and partnerships
  • Screening of cybersecurity, AI, autonomy, sensing, and space opportunities for strategic diligence

Sources and verification

This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work.

This record lists 6 public references used for company identity, status, positioning, or material-claim review.

Public sources

The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.

Investor Lens

What this entry is

Fund

Why it may matter

OurCrowd may matter as a Cloud & Developer Infrastructure entry with fund/manager research for Israeli technology research.

How an independent investor should read this

Fund/manager research. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.

Evidence to verify

  • Verify current status

Main investor questions

  • What fund vehicle, manager track record, reserve strategy, fees, carry, and reporting terms would actually be evaluated?
  • Does the manager have differentiated sourcing and repeatable support for Israeli technology companies?
  • What evidence would change the thesis or show that the profile is stale?

What not to infer

  • Inclusion does not imply endorsement.
  • Inclusion does not imply allocation availability or current fundraising.
  • Scores do not indicate investment suitability or expected returns.
  • Strategic importance does not automatically imply venture return potential.

Diligence questions

  • What evidence verifies OurCrowd's current customer traction, deployment status, and revenue concentration?
  • Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
  • Is there a credible national-security or public-sector use case, or is the company primarily a commercial technology asset?
  • What regulatory, procurement, and buyer-adoption constraints could slow deployment in strategic or government-adjacent markets?
  • Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?

Related sector

See the Cloud & Developer Infrastructure sector page for market context, related subcategories, and other Israeli companies in this part of the database.

Need a diligence readout?

Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.